142 related articles for article (PubMed ID: 11720774)
1. Calpain proteolysis of alpha II-spectrin in the normal adult human brain.
Huh GY; Glantz SB; Je S; Morrow JS; Kim JH
Neurosci Lett; 2001 Dec; 316(1):41-4. PubMed ID: 11720774
[TBL] [Abstract][Full Text] [Related]
2. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.
Glantz SB; Cianci CD; Iyer R; Pradhan D; Wang KK; Morrow JS
Biochemistry; 2007 Jan; 46(2):502-13. PubMed ID: 17209560
[TBL] [Abstract][Full Text] [Related]
3. Reactive protoplasmic and fibrous astrocytes contain high levels of calpain-cleaved alpha 2 spectrin.
Kim JH; Kwon SJ; Stankewich MC; Huh GY; Glantz SB; Morrow JS
Exp Mol Pathol; 2016 Feb; 100(1):1-7. PubMed ID: 26551084
[TBL] [Abstract][Full Text] [Related]
4. Assessment of calpain and caspase systems activities during ageing of two bovine muscles by degradation patterns of αII spectrin and PARP-1.
Saccà E; Pizzutti N; Corazzin M; Lippe G; Piasentier E
Anim Sci J; 2016 Mar; 87(3):462-6. PubMed ID: 26950517
[TBL] [Abstract][Full Text] [Related]
5. Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions.
Kobeissy FH; Liu MC; Yang Z; Zhang Z; Zheng W; Glushakova O; Mondello S; Anagli J; Hayes RL; Wang KK
Mol Neurobiol; 2015 Aug; 52(1):696-709. PubMed ID: 25270371
[TBL] [Abstract][Full Text] [Related]
6. Degradation of spectrin via calpains in the ventral horn after transient spinal cord ischemia in rabbits.
Lee JC; Hwang IK; Yoo KY; Kim DS; Kim WK; Won MH
Neurochem Res; 2006 Jul; 31(7):989-98. PubMed ID: 16847592
[TBL] [Abstract][Full Text] [Related]
7. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways.
Zhang Z; Larner SF; Liu MC; Zheng W; Hayes RL; Wang KK
Apoptosis; 2009 Nov; 14(11):1289-98. PubMed ID: 19771521
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat.
Newcomb JK; Kampfl A; Posmantur RM; Zhao X; Pike BR; Liu SJ; Clifton GL; Hayes RL
J Neurotrauma; 1997 Jun; 14(6):369-83. PubMed ID: 9219852
[TBL] [Abstract][Full Text] [Related]
10. An alpha II spectrin mutant peptide with unstable scaffold structure and increased sensitivity to calpain cleavage.
Skrzymowska J; Zalas M; Goszczyński TM; Miazek A
Biochem Biophys Res Commun; 2021 Dec; 581():68-73. PubMed ID: 34656850
[TBL] [Abstract][Full Text] [Related]
11. c-Src binds alpha II spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr1176.
Nedrelow JH; Cianci CD; Morrow JS
J Biol Chem; 2003 Feb; 278(9):7735-41. PubMed ID: 12446661
[TBL] [Abstract][Full Text] [Related]
12. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
[TBL] [Abstract][Full Text] [Related]
13. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
Cardali S; Maugeri R
J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent ataxia and neurodegeneration caused by an αII spectrin mutation with impaired regulation of its calpain sensitivity.
Miazek A; Zalas M; Skrzymowska J; Bogin BA; Grzymajło K; Goszczynski TM; Levine ZA; Morrow JS; Stankewich MC
Sci Rep; 2021 Mar; 11(1):7312. PubMed ID: 33790315
[TBL] [Abstract][Full Text] [Related]
16. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat.
Saatman KE; Bozyczko-Coyne D; Marcy V; Siman R; McIntosh TK
J Neuropathol Exp Neurol; 1996 Jul; 55(7):850-60. PubMed ID: 8965100
[TBL] [Abstract][Full Text] [Related]
17. Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells.
Czogalla A; Sikorski AF
Cell Mol Life Sci; 2005 Sep; 62(17):1913-24. PubMed ID: 15990959
[TBL] [Abstract][Full Text] [Related]
18. A mutant alphaII-spectrin designed to resist calpain and caspase cleavage questions the functional importance of this process in vivo.
Meary F; Metral S; Ferreira C; Eladari D; Colin Y; Lecomte MC; Nicolas G
J Biol Chem; 2007 May; 282(19):14226-37. PubMed ID: 17374614
[TBL] [Abstract][Full Text] [Related]
19. Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.
Saatman KE; Zhang C; Bartus RT; McIntosh TK
J Cereb Blood Flow Metab; 2000 Jan; 20(1):66-73. PubMed ID: 10616794
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin stimulates the degradation of brain spectrin by calpain.
Seubert P; Baudry M; Dudek S; Lynch G
Synapse; 1987; 1(1):20-4. PubMed ID: 2850618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
